Cipla can test Rs 450: Gujral
Ashwani Gujral (Technical Analyst), is of the view that Cipla shares can test Rs 450 level soon.
“Pharma is the only sector which is making fresh highs but that can’t take the market beyond 5200. Above Rs 310 Cipla is poised for levels of about Rs 450 over the medium term.”
He further added, “Biocon could now head upto Rs 332. It has got support at Rs 280.”
Cipla has touched a 52-week high of Rs 362.90. Its marketcap is Rs 28,523.78 crore and currently it is 107.02% above the 52-week low of Rs 171.60.
Source : MoneyControl
Related posts:
- Buy Reliance @ Rs 900-950 for Long Term : Gujral Ashwani Gujral (Technical Analyst), is of the view that “In...
- Cipla to raise Rs 676 crore via QIP Cipla is a pharmaceutical major of India and is planning...
- Yes Bank can test Rs 327: Motilal Oswal Motilal Oswal is bullish on Yes Bank and has recommended...
- ARSS Infrastructure IPO : Lists with big gain ARSS Infrastructure IPO listed with a huge premium of Rs...
Related posts brought to you by Yet Another Related Posts Plugin.
Activity